Clear Search

Saving Lives, Improving Outcomes

The research BCRF funds is transforming lives today. A woman with an inherited gene mutation can take action to minimize her risk of breast cancer. Another is diagnosed at the earliest possible stage: zero. A doctor can unravel a tumor’s intricacies to predict how a patient will respond to treatment. Each day and every dollar bring us closer to our ultimate goal of a world without breast cancer. Read how people are advancing—and benefitting from—research in BCRF’s areas of focus.

Heredity & Ethnicity

While most people who develop breast cancer have no family history, the disease can be influenced by race, ethnicity, and genetics. After learning she carried the PALB2 gene mutation and had breast cancer, Melissa Cáceres was able to take action for her health.

READ MELISSA'S STORY

Metastasis

Metastatic breast cancer causes virtually all deaths from the disease and has no cure. As a mom living with this form, Samantha Griffith Shoobs finds comfort in the rapidly accelerating pace of research advancements.

READ SAMANTHA'S STORY

Tumor Biology

Kate Williams was diagnosed with triple-negative breast cancer just months after giving birth to her daughter. Thanks to research, we’re learning more about this aggressive form of the disease and devising new treatments—so women like Kate can see their children grow up.

READ KATE'S STORY

Lifestyle & Prevention

Because of research, we know that certain lifestyle modifications can reduce one’s risk of breast cancer and recurrence. With BCRF support, Dr. Neil Iyengar is devising ways to help survivors—like his mom, Uma—make healthy changes.

READ DR. IYENGAR'S STORY

Survivorship

When Tracey found out she had stage 1 breast cancer at 45 years old, she was shocked—and then determined to make big changes. Thanks to successful treatment and a new perspective, today Tracey lives a full life.

READ TRACEY'S STORY

Treatment

BCRF investigator Dr. Lawrence Shulman has had a front row seat for every major advancement in breast cancer research since he entered the field in the 1970s. Today, he’s working to bring new treatments to under-resourced communities in the U.S. and abroad.

READ DR. SHULMAN'S STORY